CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
(CIML) natural killer (NK) cell therapy in recurrent, high grade ovarian cancer (HGOC).Names of the study therapies involved in thi...
Phase 1
Boston, Massachusetts, United States and 1 other location
The goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated w...
Phase 2
Boston, Massachusetts, United States and 25 other locations
This research study is studying a combination of targeted therapies as a possible treatment for estrogen-receptor positive (ER+) endometrial cancer...
Phase 2
Boston, Massachusetts, United States and 2 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Boston, Massachusetts, United States and 125 other locations
in combination with paclitaxel and carboplatin (AUC4) when compared with carboplatin (AUC6) and paclitaxel alone in patients with advanced ovarian...
Phase 2
Boston, Massachusetts, United States and 41 other locations
(PK), and pharmacodynamics (PD) of ZN-c3 in combination with niraparib and of ZN-c3 Monotherapy in subjects with platinum-resistant ovarian ....
Phase 1, Phase 2
Providence, Rhode Island, United States and 19 other locations
positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...
Phase 2
Boston, Massachusetts, United States and 70 other locations
This research study is evaluating three drugs called Nivolumab, Bevacizumab, and Rucaparib as a possible treatment for relapsed Relapsed Ovarian...
Phase 2
Boston, Massachusetts, United States and 2 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Boston, Massachusetts, United States and 176 other locations
of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with platinum resistant or refractory high-grade serous ovarian...
Phase 3
Boston, Massachusetts, United States and 113 other locations
Clinical trials
Research sites
Resources
Legal